PNT
POINT Biopharma Global Inc. Common Stock
Delisted
PNT was delisted on the 26th of December, 2023.
21 hedge funds and large institutions have $198M invested in POINT Biopharma Global Inc. Common Stock in 2021 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 7 increasing their positions, 5 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
21
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$24.7M | |
| 2 | +$20.6M | |
| 3 | +$11.3M | |
| 4 |
JJIJ
Johnson & Johnson Innovation - JJDC
New Brunswick,
New Jersey
|
+$10.3M |
| 5 |
BC
Boxer Capital
San Diego,
California
|
+$10.3M |
Top Sellers
| 1 | -$10.5M | |
| 2 | -$10.5M | |
| 3 | -$10.5M | |
| 4 |
LGM
Logos Global Management
San Francisco,
California
|
-$5.25M |
| 5 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$5.25M |